Vishal Goyal

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Model‐Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic Modeling
  CPT: Pharmacometrics & Systems Pharmacology 2025 DOI: 10.1002/psp4.13309
  +Save
• Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis
  Clinical and Translational Science 2024 DOI: 10.1111/cts.13908
  +Save
• Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study in healthy volunteers
  Clinical and Translational Science 2024 DOI: 10.1111/cts.13756
  +Save
• Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
  PLOS Neglected Tropical Diseases 2019 DOI: 10.1371/journal.pntd.0007726
  +Save
• Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
  PLOS Neglected Tropical Diseases 2018 DOI: 10.1371/journal.pntd.0006830
  +Save
• Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
  PLOS Neglected Tropical Diseases 2017 DOI: 10.1371/journal.pntd.0005635
  +Save